Press Releases | Page 5 of 43

New Gene Linked to Aggressive, Treatment-Resistant Prostate Cancer

August 11, 2025

“These findings highlight that, in PC, RSPO2 functions as a unique member of the R-spondin family by promoting genes and signaling pathways associated with aggressive PC, and RSPO2 amplifications are… read more

Oncotarget

Comprehensive Genomic Testing Reveals Treatment Targets in 90% of Advanced Solid Tumors

July 29, 2025

“The broad capabilities of the OncoExTra assay detected therapeutically actionable and other clinically relevant genomic events that can inform clinical decision-making for patients with advanced solid tumors.” BUFFALO, NY -… read more

Oncotarget

Blood Filtration Stabilizes Advanced Pancreatic Cancer: A Case Report

July 24, 2025

“Therapeutic modalities that explore CTC removal via blood filtration may potentially have promising clinical benefits.” BUFFALO, NY - July 24, 2025 – A new case report was published in Volume… read more

Oncotarget

Cholesterol-Lowering Drugs Show Promise Against Colorectal Cancer

July 22, 2025

“Our findings provide direct evidence that statins selectively modulate key components of the Wnt/β-catenin signaling pathway, a major driver of adenoma formation, including members of the special AT-rich sequence-binding (SATB)… read more

Oncotarget

microRNAs Emerge as Biomarkers and Diagnostic Tools in Soft Tissue Sarcoma

July 18, 2025

“[...] miRNAs are pivotal in regulating gene expression in STS and have been recognized as crucial biomarkers for the diagnosis, prognosis, and therapeutic decision-making in patients.” BUFFALO, NY - July… read more

Oncotarget

New Antibody Selectively Targets Immune Cells That Suppress Anti-Tumor Responses

July 16, 2025

“Taken together, our studies suggest that 2B010 represents an anti-CD25 mAb with unique properties in that it deleted Treg from an inflammatory environment (GVHD) as well as from the TME.”… read more